Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

424.04 1.95 +0.46%
Market cap
$91.5B
P/E
18.8×
Fwd P/E
20.3×
Dividend yield
1.62%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. (ELV) EV/FCF

Alert me on EV/FCF

As of 13 October 2026, Elevance Health, Inc. (ELV) trades at a EV/FCF of 13.6×. Over the past ten years it has ranged from 5.2× (September 2020) to 149× (September 2024); the current reading is higher than 58% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.4× 30.50%
FY2024 17.9× 19.59%
FY2023 15.0× (1.25%)
FY2022 15.2× 7.59%
FY2021 14.1× 95.44%
FY2020 7.2× (49.24%)
FY2019 14.2× (40.94%)
FY2018 24.1× 55.19%
FY2017 15.5× 43.11%
FY2016 10.8× 27.02%

Quarterly newest first

Period EV/FCF Change
Jun 2026 12.3× 36.04%
Mar 2026 9.1× (61.33%)
Dec 2025 23.4× 29.96%
Sep 2025 18.0× 16.35%
42 more quarters

Against its own ten years

Low 5.2× High 149×
Ten-year median 12.5×
Current reading's percentile 54

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on ELV